We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 961 results
  1. HIV

    Acquired immunodeficiency syndrome (AIDS) is a life-threatening chronic condition caused by the human immunodeficiency virus (HIV). HIV infection...
    Stefano Buttò, Elena Vittoria Longhi in Managing Psychosexual Consequences in Chronic Diseases
    Chapter 2023
  2. Novel role of mortalin in attenuating HIV-1 Tat-mediated astrogliosis

    Background

    In human immunodeficiency virus-1 (HIV-1) infection, activation of astrocytes induces imbalance in physiological functions due to perturbed...

    Priyanka, Renu Wadhwa, ... Pankaj Seth in Journal of Neuroinflammation
    Article Open access 20 September 2020
  3. Addressing an HIV cure in LMIC

    HIV-1 persists in infected individuals despite years of antiretroviral therapy (ART), due to the formation of a stable and long-lived latent viral...

    Sherazaan D. Ismail, Joshua Pankrac, ... Eric J. Arts in Retrovirology
    Article Open access 03 August 2021
  4. Macrophage Targeting for Therapy of HIV

    HIV is a global threat, not only from today but for ages as nearly 25 million people have died due to this curse of nature and approximately 40...
    Sakshi Nainwani, Anushka Tyagi, ... Swati Gupta in Macrophage Targeted Delivery Systems
    Chapter 2022
  5. HIV-1 and HBV RNase H as Metal-Chelating Inhibitors: Discovery and Medicinal Chemistry Strategies

    Human immunodeficiency viruses (HIV) andHuman Immunodeficiency virus (HIV) hepatitis B viruses (HBV) areHepatitis B virus (HBV) highly pathogenic...
    Fenju Wei, Edeildo Ferreira da Silva-Júnior, ... Peng Zhan in Human Viruses: Diseases, Treatments and Vaccines
    Chapter 2021
  6. MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV

    Human immunodeficiency virus (HIV) and human T cell leukemia virus (HTLV) have replicative and latent stages of infection. The status of the viruses...

    Sergio P. Alpuche-Lazcano, Robert J. Scarborough, Anne Gatignol in Retrovirology
    Article Open access 29 February 2024
  7. Herpesviruses

    The herpesviruses are large, enveloped DNA viruses, measuring 120–200 nm in diameter. They exhibit many common features, such as similar morphology...
    Subhash Chandra Parija in Textbook of Microbiology and Immunology
    Chapter 2023
  8. Virtual memory CD8+ T cells restrain the viral reservoir in HIV-1-infected patients with antiretroviral therapy through derepressing KIR-mediated inhibition

    The viral reservoir is the major hurdle in develo** and establishing an HIV cure. Understanding factors affecting the size and decay of this...

    Jie-Hua **, Hui-Huang Huang, ... Fu-Sheng Wang in Cellular & Molecular Immunology
    Article 24 March 2020
  9. Purinergic signaling in the battlefield of viral infections

    Purinergic signaling has been associated with immune defenses against pathogens such as bacteria, protozoa, fungi, and viruses, acting as a sentinel...

    Nayara Carvalho-Barbosa, Julianna Dias Zeidler, ... Robson Coutinho-Silva in Purinergic Signalling
    Article 01 December 2023
  10. Inhalation Therapy in Pulmonary Tuberculosis

    Tuberculosis (TB) is a historical disease that can trace its impact on humanityHumanity back in time thousands of years. A bacterial...
    Thomas Manning, Jenu Thomas-Richardson, ... Greg Wylie in Tuberculosis
    Chapter 2023
  11. Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates

    In this study, we demonstrate the safety and utility of CRISPR-Cas9 gene editing technology for in vivo editing of proviral DNA in ART-treated,...

    Tricia H. Burdo, Chen Chen, ... Kamel Khalili in Gene Therapy
    Article Open access 17 August 2023
  12. New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes

    The main objective of the MACIVIVA European consortium was to develop new Good Manufacturing Practice pilot lines for manufacturing thermostable...

    Mario Amacker, Charli Smardon, ... Sylvain Fleury in npj Vaccines
    Article Open access 18 May 2020
  13. Droplet-microfluidics-assisted sequencing of HIV proviruses and their integration sites in cells from people on antiretroviral therapy

    The human immunodeficiency virus (HIV) integrates its genome into that of infected cells and may enter an inactive state of reversible latency that...

    Chen Sun, Leqian Liu, ... Adam R. Abate in Nature Biomedical Engineering
    Article 28 March 2022
  14. A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro

    Objective

    Resting CD4 + T cells are major reservoirs of latent HIV-1 infection, and may be formed during the early phase of the infection. Although...

    Kazutaka Terahara, Ryutaro Iwabuchi, ... Yasuko Tsunetsugu-Yokota in BMC Research Notes
    Article Open access 29 April 2019
  15. Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study

    Background

    Patients with human immunodeficiency virus-associated cryptococcal meningitis (HIV-CM) have persistent intracranial inflammation despite...

    Zhikai Wan, Ran Tao, ... Biao Zhu in Journal of Neuroinflammation
    Article Open access 15 February 2023
  16. A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication

    Background

    The persistence of HIV-1 in reservoir cells is one of the major obstacles to eradicating the virus in infected individuals receiving...

    Chiara Orlandi, Benedetta Canovari, ... Anna Casabianca in Journal of Translational Medicine
    Article Open access 19 May 2020
  17. NNRTI-induced HIV-1 protease-mediated cytotoxicity induces rapid death of CD4 T cells during productive infection and latency reversal

    Background

    Current efforts towards HIV-1 eradication focus on the reactivation and elimination of the latent viral reservoir, so-called shock and kill...

    Benjamin Trinité, Hongtao Zhang, David N. Levy in Retrovirology
    Article Open access 26 June 2019
  18. Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure

    Following reverse transcription, HIV viral DNA is integrated into host cell genomes and establishes a stable latent infection, which has posed a...

    Edrous Alamer, Chaojie Zhong, ... Haitao Hu in Retrovirology
    Article Open access 07 January 2021
  19. Generation of Anti-HIV CAR-T Cells for Preclinical Research

    The inability of people living with HIV (PLWH) to eradicate human immunodeficiency virus (HIV) infection is due in part to the inadequate...
    Hang Su, Kim Anthony-Gonda, ... Harris Goldstein in HIV Protocols
    Protocol 2024
  20. Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques

    Develo** an intervention that results in virologic control following discontinuation of antiretroviral therapy (ART) is a major objective of HIV-1...

    John D. Ventura, Joseph P. Nkolola, ... Dan H. Barouch in npj Vaccines
    Article Open access 18 May 2022
Did you find what you were looking for? Share feedback.